USANA Health Sciences, Inc. (USNA): Price and Financial Metrics


USANA Health Sciences, Inc. (USNA): $95.55

0.58 (+0.61%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

USNA POWR Grades


  • Quality is the dimension where USNA ranks best; there it ranks ahead of 99.94% of US stocks.
  • The strongest trend for USNA is in Growth, which has been heading down over the past 169 days.
  • USNA ranks lowest in Momentum; there it ranks in the 18th percentile.

USNA Stock Summary

  • Usana Health Sciences Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 84.75% of US listed stocks.
  • For USNA, its debt to operating expenses ratio is greater than that reported by just 0.39% of US equities we're observing.
  • In terms of volatility of its share price, USNA is more volatile than only 6.76% of stocks we're observing.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Usana Health Sciences Inc are NATR, PATI, KEX, SRGA, and CVEO.
  • USNA's SEC filings can be seen here. And to visit Usana Health Sciences Inc's official web site, go to www.usana.com.

USNA Valuation Summary

  • In comparison to the median Consumer Defensive stock, USNA's EV/EBIT ratio is 51.67% lower, now standing at 8.7.
  • Over the past 243 months, USNA's price/sales ratio has gone up 1.5.
  • Over the past 243 months, USNA's price/sales ratio has gone up 1.5.

Below are key valuation metrics over time for USNA.

Stock Date P/S P/B P/E EV/EBIT
USNA 2021-09-03 1.6 4.7 14.2 8.7
USNA 2021-09-02 1.5 4.6 14.0 8.5
USNA 2021-09-01 1.6 4.7 14.1 8.5
USNA 2021-08-31 1.5 4.6 14.0 8.5
USNA 2021-08-30 1.6 4.7 14.0 8.5
USNA 2021-08-27 1.6 4.7 14.1 8.5

USNA Growth Metrics

    Its 2 year net income to common stockholders growth rate is now at 46.75%.
  • Its 5 year cash and equivalents growth rate is now at 28.97%.
  • Its 3 year net cashflow from operations growth rate is now at 36.25%.
Over the past 33 months, USNA's revenue has gone up $40,438,000.

The table below shows USNA's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-09-30 1,229.686 144.22 135.814
2021-06-30 1,253.847 155.794 138.99
2021-03-31 1,176.001 149.274 128.733
2020-12-31 1,134.644 160.401 124.664
2020-09-30 1,095.421 168.226 115.789
2020-06-30 1,057.506 169.478 109.505

USNA's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • USNA has a Quality Grade of A, ranking ahead of 99.94% of graded US stocks.
  • USNA's asset turnover comes in at 2.095 -- ranking 5th of 681 Pharmaceutical Products stocks.
  • RGLS, ANIP, and VTVT are the stocks whose asset turnover ratios are most correlated with USNA.

The table below shows USNA's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-07-03 2.095 0.817 1.727
2021-04-03 2.032 0.812 1.699
2021-01-02 2.059 0.816 1.726
2020-09-26 2.106 0.820 1.707
2020-06-27 2.152 0.821 1.560
2020-03-28 2.124 0.822 1.401

USNA Stock Price Chart Interactive Chart >

Price chart for USNA

USNA Price/Volume Stats

Current price $95.55 52-week high $107.85
Prev. close $94.97 52-week low $80.00
Day low $93.50 Volume 37,503
Day high $95.56 Avg. volume 49,358
50-day MA $100.40 Dividend yield N/A
200-day MA $98.79 Market Cap 1.86B

USANA Health Sciences, Inc. (USNA) Company Bio


USANA Health Sciences develops and manufactures nutritional supplements, healthy foods and personal care products. The company was founded in 1992 and is based in Salt Lake City, Utah.


USNA Latest News Stream


Event/Time News Detail
Loading, please wait...

USNA Latest Social Stream


Loading social stream, please wait...

View Full USNA Social Stream

Latest USNA News From Around the Web

Below are the latest news stories about Usana Health Sciences Inc that investors may wish to consider to help them evaluate USNA as an investment opportunity.

3 Surprising Benefits of National Stairs Day

National 'Take the Stairs Day' Jan. 12 can lift workers in three ways beyond physical health. So says bestselling author who motivates audiences around the world to reach their fullest potential.

Yahoo | January 11, 2022

USANA Schedules Fourth Quarter and FY 2021 Earnings Release and Conference Call

SALT LAKE CITY, January 06, 2022--USANA Health Sciences, Inc. (NYSE:USNA) today announced that fourth quarter and FY 2021 results will be released after the close of market on Tuesday, February 8, 2022. Shortly following the issuance of the Company’s earnings release, the Company will post its Management Commentary document on the Company’s website (http://ir.usana.com) under the Investor Relations section of the site. USANA will hold a conference call to discuss this announcement with analysts

Yahoo | January 6, 2022

Here's What USANA Health Sciences' (NYSE:USNA) Strong Returns On Capital Mean

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'd want to...

Yahoo | January 4, 2022

USANA Canada Takes Home Top DSA Awards

USANA Canada is proud to announce its General Manager Tracie Graham was honored with the Canadian Direct Selling Association's Ivan P. Phelan award. Two USANA Associates, Seta Der Artinian and Hubert Krause, also earned the DSA "Mark of Distinction."

Yahoo | December 28, 2021

ChemoCentryx's (CCXI) Stock Increases on Tavneos' FDA Nod

ChemoCentryx's (CCXI) Tavneos gives a significant boost to the company, following its FDA approval in ANCA-associated vasculitis. The drug is also being evaluated in other indications.

Yahoo | December 27, 2021

Read More 'USNA' Stories Here

USNA Price Returns

1-mo -6.33%
3-mo -1.56%
6-mo 0.29%
1-year 11.12%
3-year -17.24%
5-year 54.36%
YTD -5.58%
2021 31.26%
2020 -1.85%
2019 -33.28%
2018 58.99%
2017 21.00%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.9751 seconds.